Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CRB-913

CANYON-1

Corbus Pharmaceuticals · Phase 1 · Completed · Enrollment 254

NCT07310901

ArmPopulationDoseWeeksEstimandWeight change
Part 1: PK Lead-inObese But Otherwise Healthy Participantsn/rn/rn/rn/r
Part 2: CRB-913 low doseObese But Otherwise Healthy Participantsn/rn/rn/rn/r
Part 2: CRB-913 Medium DoseObese But Otherwise Healthy Participantsn/rn/rn/rn/r
Part 2: CRB-913 High DoseObese But Otherwise Healthy Participantsn/rn/rn/rn/r
Part 2: PlaceboObese But Otherwise Healthy Participantsn/rn/rn/rn/r